Literature DB >> 16631734

Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage.

Yi-Ruu Lin1, Hwei-Hsien Chen, Chien-Hsin Ko, Ming-Huan Chan.   

Abstract

The aim of the present study was to investigate the neuroprotective effects of honokiol and magnolol, two major bioactive constituents of the bark of Magnolia officinalis, against neuron toxicity induced by glucose deprivation, excitatory amino acids and hydrogen peroxide (H(2)O(2)) in cultured rat cerebellar granule cells. Cell membrane damage was measured with a lactate dehydrogenase (LDH) release assay and 3-(4,5-dimethyl-2 thiazoyl)-2,5-diphenyl-tetrazolium bromide (MTT) assay was used to assess mitochondrial activity, reflecting cell survival. Results showed that honokiol and magnolol alone did not affect mitochondrial function and cell damage, but significantly reversed glucose deprivation-induced mitochondrial dysfunction and cell damage. The glutamate receptor blocker MK-801 and antioxidant vitamin E also provided protection against this damage. Furthermore, honokiol was more potent than magnolol in protecting against glutamate-, N-methyl-D-aspartate (NMDA)- and H(2)O(2)-induced mitochondrial dysfunction. These results demonstrated that the neuroprotective effects of honokiol and magnolol may be related to their anti-oxidative actions and antagonism of excitotoxicity induced by excitatory amino acids, suggesting that both compounds may be potential therapeutic agents for neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631734     DOI: 10.1016/j.ejphar.2006.03.035

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  36 in total

1.  Separation and determination of honokiol and magnolol in Chinese traditional medicines by capillary electrophoresis with the application of response surface methodology and radial basis function neural network.

Authors:  Ping Han; Feng Luan; Xizu Yan; Yuan Gao; Huitao Liu
Journal:  J Chromatogr Sci       Date:  2012-01       Impact factor: 1.618

2.  Neurite outgrowth effect of 4-O-methylhonokiol by induction of neurotrophic factors through ERK activation.

Authors:  Yong Kyoung Lee; Im Seop Choi; Young Heui Kim; Ki Ho Kim; Sang Yun Nam; Young Won Yun; Moon Soon Lee; Ki Wan Oh; Jin Tae Hong
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

3.  Inhibitory Effects of Honokiol on the Voltage-Gated Potassium Channels in Freshly Isolated Mouse Dorsal Root Ganglion Neurons.

Authors:  Anqi Sheng; Yan Zhang; Guang Li; Guangqin Zhang
Journal:  Neurochem Res       Date:  2017-11-24       Impact factor: 3.996

4.  Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.

Authors:  Atanu K Khatua; Amber M Cheatham; Etty D Kruzel; Pravin C Singhal; Karl Skorecki; Waldemar Popik
Journal:  Am J Physiol Cell Physiol       Date:  2015-04-29       Impact factor: 4.249

5.  Therapeutic Action of Honokiol on Postoperative Ileus via Downregulation of iNOS Gene Expression.

Authors:  Taiki Mihara; Shoma Mikawa; Noriyuki Kaji; Mari Endo; Tetsuro Oikawa; Jan Tong-Rong; Hiroshi Ozaki; Masatoshi Hori
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

6.  Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol.

Authors:  Gang Chen; Julie Izzo; Yusuke Demizu; Feng Wang; Sushovan Guha; Xifeng Wu; Mein-Chie Hung; Jaffer A Ajani; Peng Huang
Journal:  Antioxid Redox Signal       Date:  2009-05       Impact factor: 8.401

7.  Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function.

Authors:  Jing Pan; Qi Zhang; Qian Liu; Steven M Komas; Balaraman Kalyanaraman; Ronald A Lubet; Yian Wang; Ming You
Journal:  Cancer Prev Res (Phila)       Date:  2014-09-22

8.  Honokiol for the Treatment of Neonatal Pain and Prevention of Consequent Neurobehavioral Disorders.

Authors:  Anna Woodbury; Shan Ping Yu; Dongdong Chen; Xiaohuan Gu; Jin Hwan Lee; James Zhang; Alyssa Espinera; Paul S García; Ling Wei
Journal:  J Nat Prod       Date:  2015-11-05       Impact factor: 4.050

9.  Honokiol Restores Polymyxin Susceptibility to MCR-1-Positive Pathogens both In Vitro and In Vivo.

Authors:  Yan Guo; Xiaohong Lv; Yanling Wang; Yonglin Zhou; Na Lu; Xuming Deng; Jianfeng Wang
Journal:  Appl Environ Microbiol       Date:  2020-02-18       Impact factor: 4.792

10.  Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain.

Authors:  Yi-Ruu Lin; Hwei-Hsien Chen; Yu-Chin Lin; Chien-Hsin Ko; Ming-Huan Chan
Journal:  J Biomed Sci       Date:  2009-10-16       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.